
GC32931
LDH-IN-1
Also known as 2-[5-(cyclopropylmethyl)-3-(3-phenylphenyl)-4-[(4-sulfamoylphenyl)methyl]pyrazol-1-yl]-1,3-thiazole-4-carboxylic acid
LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively
ChemicalCAS1964515-43-2MW570.68FormulaC30H26N4O4S2
- CAS number
- 1964515-43-2
- Molecular weight
- 570.68
- Formula
- C30H26N4O4S2
- Solubility
- DMSO : 52 mg/mL (91·12 mM);Water : < 0·1 mg/mL (insoluble)
- InChIKey
- ALJORCZKMBZYCR-UHFFFAOYSA-N
- Catalogue number
- GC32931
- Brand
- GLPBIO
Computed properties PubChem CID 131955127 · XLogP 6.3 · TPSA 165 Ų · H-bond donors 2
- XLogP
- 6.3
- TPSA
- 165 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 9
- Heavy atoms
- 40
SMILES C1CC1CC2=C(C(=NN2C3=NC(=CS3)C(=O)O)C4=CC=CC(=C4)C5=CC=CC=C5)CC6=CC=C(C=C6)S(=O)(=O)N
Computed descriptors from PubChem (CID 131955127), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il